Skip to main content

Administrative Supplements to Support Cancer Disparity Collaborative Research

The Administrative Supplements to Support Cancer Disparity Collaborative Research Program (the Collaborative) seeks to catalyze and broaden research and collaborations across the Cancer Health Disparities (CHD) spectrum. The Collaborative supports new CHD research among investigators who do not normally conduct it and encourages the partnership of experienced cancer research investigators with CHD-focused researchers. The trans-NCI program aims to accelerate and strengthen multi-disciplinary CHD research in wide-ranging areas.

Key facts about the Collaborative:

  • Proposed collaborations should focus on achieving research objectives that by necessity rely on diverse and complementary expertise, technical capabilities, and resource sets.
  • Importantly, the supplemental proposal is required to be within the scope of the parent award and should expand the original aims to include a CHD component and possible inclusion of international comparator cohorts.

The Collaborative Funding Opportunity Announcement is PAR-22-114. Access the Collaborative Frequently Asked Questions.

Title & CRCHD Contact

Application Due Date & Purpose

Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional)

Dr. Maria Jamela (Jay) Revilleza
(240) 620-0616

Due Dates: *NEW: September 23, 2022;* January 23, 2023; September 6, 2023; January 23, 2024; September 6, 2024; January 23, 2025

The purpose of the Collaborative is to promote cancer disparities research among NCI-funded non-disparity researchers and encourage collaboration with cancer disparities-focused researchers, as well as to accelerate and strengthen multi-disciplinary cancer disparities research in wide-ranging areas.

 

  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Administrative Supplements to Support Cancer Disparity Collaborative Research was originally published by the National Cancer Institute.”